The page is the record's research on the issuer — no analyst, no rating, no view. # Caribou Biosciences, Inc. (NASDAQ: CRBU) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing Caribou Biosciences, Inc. is listed on NASDAQ under the ticker CRBU, with ISIN US1420381089. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-DE. The security type is Corporate, the segment is not on the record, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is United States, Delaware. The issuer is listed and not halted. ## The disclosure read The record holds 39 filings across 18 filing days in the window 2025-11-08 to 2026-11-08. Of these, 14 are directors' dealings, 10 are results, 7 are regulatory filings, 5 are AGM/EGM filings, 2 are corporate news, and 1 is a director change. The median gap between filing days is 10 days. The latest filing is a results filing dated 2026-11-05, 3 days before the record date of 2026-11-08. The NASDAQ peer median is 52 filings, a cadence gap of 6.0 days, and a latency of 5.0 days across 4,359 issuers. The sector peer median is 65.5 filings, a cadence gap of 5.5 days, and a latency of 4.0 days across 176 issuers. ## Auditor The auditor of record is Deloitte & Touche LLP, located in San Francisco, California. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting, or name change events. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is not set. ## Orderability The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, with the chapter as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The earliest sealed date for the US market is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001619856.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/CRBU (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1619856/000161985626000008/crbu-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/CRBU (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/CRBU · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp